|
Volumn 188, Issue 12, 2013, Pages 1387-1388
|
Large chronic obstructive pulmonary disease cohorts: Advantages and caution in biomarker discovery/validation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ASYMPTOMATIC DISEASE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DISEASE COURSE;
DISEASE MARKER;
EDITORIAL;
FORCED EXPIRATORY VOLUME;
HUMAN;
LUNG EMPHYSEMA;
NONHUMAN;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
SALIVA ANALYSIS;
SMOKING;
SPIROMETRY;
VALIDATION STUDY;
ANIMALS;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
MALE;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
UTEROGLOBIN;
|
EID: 84890475741
PISSN: 1073449X
EISSN: 15354970
Source Type: Journal
DOI: 10.1164/rccm.201311-2001ED Document Type: Editorial |
Times cited : (2)
|
References (6)
|